We also tested the association between PARP1 and PARP2 expression with clinical outcome by quantitative real‐time PCR (RT‐qPCR) analysis of 20 mRNA samples extracted from stage 4 neuroblastomas. This evidence concerns the gene PARP1 and neuroblastoma.